| Autor: |
Michihiro Hide, Takamasa Suzuki, Ayaka Tanaka, Hiroshi Aoki |
| Jazyk: |
angličtina |
| Rok vydání: |
2019 |
| Předmět: |
|
| Zdroj: |
Allergology International, Vol 68, Iss 1, Pp 59-67 (2019) |
| Druh dokumentu: |
article |
| ISSN: |
1323-8930 |
| DOI: |
10.1016/j.alit.2018.06.002 |
| Popis: |
Background: Rupatadine, a novel nonsedating second-generation H1-antihistamine with antiplatelet-activating factor activity, has been used in the treatment of allergic rhinitis and urticaria in European countries since 2003. However, its efficacy and safety in Japanese patients with chronic spontaneous urticaria (CSU) are unknown. Methods: We conducted a prospective, multicenter, randomized, placebo-controlled, double-blind study in adolescent and adult CSU outpatients aged 12 to |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
